Children with sickle cell disease (SCD) are at an increased risk for sleep disorders as compared to healthy children, possibly because of disease processes, pain, minority status and living in an urban environment. Adequate sleep is an essential component of typical development, moodand-affect regulation and health maintenance, but more research is needed to understand the contribution of sleep to health outcomes in children with SCD. AS SCD is a chronic disease that can be affected by environmental, health, and behavioural factors, understanding the impact of the disease on sleep is important to maximise the quality of life in these children. If the disease causes poor sleep quality, then children may be at risk for a host of developmental and psychosocial problems, beyond those caused by SCD, as a result of inadequate sleep. Also, poor sleep may affect the disease course, thus exacerbating symptoms. Prevalent sleep disorders in this population are reviewed, including sleep-disordered breathing, periodic limb movements, restless legs syndrome and nocturnal enuresis. Also, the contribution of the disease symptoms pain, hypoxaemia, daytime tiredness and fatigue to disrupted sleep are examined. Finally, the effects of sociodemographic factors, such as poverty and minority status, are described, as these contextual factors significantly impact sleep across several chronic conditions in paediatrics. Frequent monitoring for sleep disruptions can be essential to improving health outcomes and quality of life in children with SCD.
The symptoms of sickle cell disease (SCD) as well as underlying disease processes affect sleep across development, which has important implications for academic and behavioural functioning and overall health outcomes in children and adolescents with SCD. High frequencies of arousals and fragmented sleep related to sleep disorders that are more prevalent in SCD coupled with sleep-interfering disease symptoms (i.e. pain, enuresis, hypoxaemia) result in chronic sleep disruption that can affect development and health outcomes. Rates of sleep-disordered breathing conditions, including obstructive sleep apnoea (OSA), [1] [2] [3] periodic limb movements (PLMS), 4 restless legs syndrome 4 and nocturnal enuresis 5, 6 have been documented in children and adolescents with SCD compared to healthy peers. In children without chronic illness, sleep problems have been linked to behaviour problems, 7 poor academic outcomes, 
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Sleep-disordered Breathing
Sleep-disordered breathing is one of the most frequently observed sleep disorders in children with SCD and can significantly impact health and behavioural outcomes in child development.
Sleep-disordered breathing refers to the category of disorders of abnormal respiration during the night, either based on ventilation patterns or quantity of ventilation throughout the night. 11 OSA is the most common of these disorders, caused by a collapse of the upper airway that restricts airflow and causes hypoxia, disruptions in sleep, hypercapnia (increased carbon dioxide) and reduced neurocognitive performance. 11 Sleep-disordered breathing contributes to behavioural problems and learning difficulties (for a review see Owens 12 ), pulmonary hypertension, arterial hypertension, nocturnal enuresis and reductions in growth. 13 A handful of studies have described the occurrence of sleep-disordered breathing and OSA in children and adolescents with SCD using polysomnography (PSG), the gold standard for diagnosing sleep-disordered breathing. Three studies have described rates of sleep-disordered breathing in children and adolescents clinically referred for PSG because of suspected sleep-disordered breathing. [1] [2] [3] Most recently, 69 % of children with either SCD genotypes HbSS or HbSC were diagnosed with OSA using PSG with no difference in diagnosis between the two genotypes. 2 14 In a descriptive study of 50 10-18 year old children and adolescents with the genotype HbSS, oxyhaemoglobin desaturation during rapid eye movement sleep (<93 %) was related to higher rates of obstructive apnoeic events, higher heart rates during sleep and higher waking heart rates. 15 Souza and Viegas suggest that the higher levels of sleep-disordered breathing in patients with oxyhaemoglobin desaturation during rapid eye movement sleep is related to diurnal desaturation rather than to pulmonary events, 15 as previously suggested in other studies. 16 Higher rates of sleep-disordered breathing may be caused by enlarged tonsils and adenoids that block airflow as the result of more frequent childhood infections secondary to early spleen damage. 17 Alternatively, adenotonsillar hypertrophy may be related to compensatory lymphoid tissue enlargement.
Successful treatment of OSA in children with SCD using adenotonsillectomy has been described in two small studies.
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Maddern et al. found that in 13 children who underwent surgery there were fewer subjective sleep complaints (e.g. restlessness, wakings, sleepiness), lower end-tidal CO 2 on PSG, shorter apnoeas, but no difference in the number of apnoeic events when compared to baseline PSG. 18 Samuels et al. found a significant reduction in nocturnal hypoxaemia or in some cases no hypoxaemia on the night studied in 15 patients post-surgery. 3 Although not a pre/post examination of surgical intervention, Rogers et al. described PSG variables in children who underwent adenotonsillectomy and found that 8 of 10 children continued to meet criteria for sleep-disordered breathing, but overall rates of apnoeic events were lower compared to children with OSA who had not undergone surgery. 2 The continued occurrence of obstructive events post-surgery may be due to more severe cases of OSA leading to referral to surgery. There are increased risks for using surgical intervention in patients with SCD including anaemia, hypoxia and higher rates of post-operative complications; however, surgery can produce significant improvement with protocols to reduce sickling and hypoxaemia. 18 
Periodic Limb Movements and Restless Legs Syndrome
PLMS and RLS are related but separate neurological conditions that can occur in pediatric SCD. PLMS are short, repetitive movements of the arms and legs that occur during sleep and are sometimes associated with arousal and/or sleep fragmentation. 19 RLS is a sensorimotor disorder that results in the urge to move one's legs to relieve uncomfortable sensations that occur when resting.
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Subjectively, patients report experiencing tingling or 'creepy-crawly' sensations in their legs that is relieved by moving the legs. 20 Although these sensations may occur throughout the day, they are associated with inactivity and thus they are most evident upon lying down to sleep. 20 Diagnosis of PLMS occurs during PSG, while RLS is a clinical diagnosis. 19 Both conditions are associated with low iron, and thus serum ferritin levels are often important to diagnosis and treatment.
Rogers et al. 4 described the increased occurrence of PLMS and RLS in 64 children and adolescents with HbSS who were not currently receiving transfusion or hydroyurea. Almost a quarter of the sample (23.4 %) had PLMS at a rate of at least five events per hour, the cut off for diagnosis of periodic limb movement disorder. PLMS appeared to be unrelated to the occurrence of OSA in this sample.
This rate is significantly higher than previous reports in healthy children that estimated prevalence at 2.2 %. 21 Clinical assessment indicated that 12 % of the sample experienced symptoms of RLS, and these symptoms were more common in children with PLMS.
Mechanisms for higher rates of PLMS and RLS among children with SCD are unclear, especially given the relationship to low serum ferritin levels in healthy children, which is not typically low in SCD due to transfusion and in response to tissue damage related to vaso-occlusive episodes. 22 The authors suggest a relationship with central nervous system iron levels, which can remain low despite normal serum levels and have been documented in adults with RLS but not in SCD 23 or disease factors that affect iron regulation. 24 
Nocturnal Enuresis
Children and adolescents with SCD are more likely to exhibit nocturnal enuresis than age-matched controls. Mechanisms of increased rates of enuresis in SCD are unclear. There has been speculation that renal damage caused by dehydration results in increased fluid consumption and urine volume. 26, 27 An alternative explanation is that enuresis is caused by lower levels of anti-diuretic hormone. 28 Additionally, enuresis is a symptom of sleep-disordered breathing, 13 which could also contribute to increased occurrence of enuresis in children with SCD. One study that examined enuresis treatments in SCD offered families the option of desmopressin acetate intranasal spray (n=10) or enuretic alarm (n=2). 28 Six of 10 patients evidenced an improvement or resolution of enuresis with the nasal spray and four did not respond. Both children using the enuretic alarm discontinued treatment after three to four months of treatment with no improvement. Larger randomised treatment studies are needed to understand whether behavioural methods or combination treatments are efficacious in children with SCD.
Disease Factors that Disrupt Sleep
Pain
The effects of pain on sleep are also a significant concern, with both acute and chronic pain in SCD. In a review of pain literature related to medical conditions, most conditions associated with pain have been shown to reduce sleep efficiency, slow-wave sleep and rapid eye movement sleep. 29 Sleep disturbances in children with chronic pain, including SCD, have been related to lower quality of life related to physical health and greater functional disability. 30 Using daily diary methodology, frequently used to monitor the occurrence and intensity of pain as well as sleep parameters and subjective reports of sleep quality, nocturnal pain was found to be a frequent occurrence for children and adolescents with SCD, occurring on 12 % of nights. 31 Shapiro et al. collected pain and sleep diaries twice a day for an average of 10 months in 18 children and adolescents. Results indicated that sleep quality was affected by SCD pain (which occurred on 30 % of the days studied), with children rating sleep quality as poor on 43 % of days with pain, as compared with 3 % of days without pain. 32 In this study, sleep duration was also significantly shorter during pain episodes.
Valrie et al. 33, 34 examined the relationship between sleep and pain in 20 children of age eight to 12 years by using daily sleep and pain diaries and reports of mood and stress for up to eight weeks. The children reported pain on 21 % of days during the course of the study, and the average pain rating on days with pain was 49.83 (on a 0-100 visual analogue scale). Controlling for demographic factors and disease type, the interaction between stress and pain severity created a model that accounted for 72 % of the variance in sleep quality and indicated that younger female patients with HbSS and greater pain severity were more likely to have poor sleep quality. 33 Further analyses indicated that children experiencing greater stress had a stronger negative relationship between pain intensity and sleep quality. Negative mood was also found to mediate partially the relationship between high pain and poor sleep quality during the night and the following day. 34 As participants' moods became more positive, the strength of the pain and sleep quality relationship decreased the following day.
Another study utilising pain and sleep diaries in 20 adolescents found a cyclical relationship between pain and sleep quality, with poor sleep preceding days with pain and days with pain being followed by poor sleep. 35 Analgesic use moderated the relationship between pain intensity and sleep quality such that, when adolescents used analgesics, the relationship between pain and sleep quality was no longer significant. This sample also reported pain on 22 % of study days, indicating marked and frequent disturbances of sleep. A study using retrospective self-reports to examine sleep in 86 adolescents with chronic pain conditions (i.e. headache, juvenile idiopathic arthritis and SCD) demonstrated a small but significant correlation between pain frequency and daytime sleepiness; also, adolescents with longer pain episodes had later bedtimes. Poor sleep before the onset of a pain episode may also be indicative of biological changes occurring that eventually cause the pain episode. 35 
Hypoxaemia
Nocturnal oxyhaemoglobin desaturation is common among children with SCD 38 and appears to be unrelated to upper airway obstructive events. 16 Oxyhaemoglobin levels can decrease substantially in children with SCD as compared to healthy controls 3 and the amount of desaturation is related to the severity of SCD, 39 occurring more frequently in children with HbSS and HbSβ0 thalassaemia subtypes compared to HbSC and HbSβ+ thalassemia. 38 Nocturnal desaturation may result in increased occurrences of vaso-occlusive episodes 40 and/or stroke. 41 Dips in oxyhaemoglobin saturation of 4 % below baseline have been associated with an average of 2.97 more days of pain per year. 40 Decreased nocturnal oxyhaemoglobin saturation may instigate pain because of the effects of desaturation on bone marrow leading to vaso-occlusive episodes 40 or because of an increased tendency for the adhesion of red blood cells to the endothelial cells in children with greater oxyhaemoglobin desaturation. 39 Nocturnal haemoglobin saturation together with arterial velocity has also been found to predict time until central nervous system events. however, similar to controls demographically matched. 44 Adolescents with SCD report similar levels of daytime sleepiness to teens with juvenile rheumatoid arthritis and less sleepiness than adolescents with chronic headaches. 36 Increased occurrence of sleep-disordered breathing in children with SCD may also contribute to higher levels of daytime sleepiness, as indicated in other populations. 45, 46 Additionally, fatigue is a known side effect of anaemia in SCD. [47] [48] [49] No studies have examined the co-occurrence of sleepiness and fatigue in children with chronic pain, and thus it is unclear whether higher levels of daytime sleepiness actually reflect fatigue. 30 Describing fatigue from a biobehavioural framework, Ameringer and Smith describe hypoxaemia and inflammation as disease variables that result in fatigue, which is further exacerbated by pain, stress and depression/anxiety experienced by children with SCD. 50 The relationship between fatigue, sleep and quality of life in children and adolescents with SCD has not been studied to date; thus further research is necessary to understand the effects of fatigue on cognitive functioning and academic performance in these children. 
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